---
title: "Krsnaa Diagnostics Publishes Unaudited Q3 and Nine-Month FY26 Results in Newspapers"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275194479.md"
description: "Krsnaa Diagnostics Limited has published its unaudited standalone and consolidated financial results for Q3 and the nine months ending December 31, 2025, in the Financial Express and Loksatta newspapers. This announcement ensures compliance with securities listing regulations, enhancing transparency for investors. The company operates in the healthcare diagnostics sector, providing affordable services through a network of diagnostic centers across India. Current market cap stands at 23.62B INR, with an average trading volume of 9,290 and a technical sentiment signal indicating a 'Sell' recommendation."
datetime: "2026-02-07T06:23:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275194479.md)
  - [en](https://longbridge.com/en/news/275194479.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275194479.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275194479.md) | [繁體中文](https://longbridge.com/zh-HK/news/275194479.md)


# Krsnaa Diagnostics Publishes Unaudited Q3 and Nine-Month FY26 Results in Newspapers

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Krsnaa Diagnostics Limited ( (IN:KRSNAA) ) just unveiled an announcement.

Krsnaa Diagnostics Limited has published newspaper advertisements of its unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025 in the English daily Financial Express and Marathi daily Loksatta. The move reflects the company’s compliance with securities listing regulations requiring public dissemination of financial information, ensuring greater transparency and access for investors and other stakeholders through both print media and its corporate website.

**More about Krsnaa Diagnostics Limited**

Krsnaa Diagnostics Limited operates in the healthcare diagnostics industry, offering pathology and radiology services through a network of diagnostic centers across India. The company focuses on providing affordable, accessible diagnostic solutions and caters to both public and private sector customers, including government contracts and hospital partnerships.

**Average Trading Volume:** 9,290

**Technical Sentiment Signal:** Sell

**Current Market Cap:** 23.62B INR

Find detailed analytics on KRSNAA stock on TipRanks’ Stock Analysis page.

## Related News & Research

- [Omeros Turns Corner With Novo Deal, YARTEMLEA Launch](https://longbridge.com/en/news/281666535.md)
- [OMER S.p.A.: Resilient Fundamentals and Structural Growth Support Buy Rating Despite Softer FY26 Outlook](https://longbridge.com/en/news/281649119.md)
- [The High-Bandwidth Memory (HBM) Bottleneck Can Still Cause Micron's Stock to Soar](https://longbridge.com/en/news/281662827.md)
- [Shenzhen Xunce Technology Co., Ltd. Class H (3317): New Buy Recommendation for This Technology Giant](https://longbridge.com/en/news/281611713.md)
- [SpaceX Valuation at $2 Trillion: How It Surpasses Meta and Tesla?](https://longbridge.com/en/news/281611627.md)